In vitro phototoxicity of 5-aminolevulinic acid and its methyl ester and the influence of barrier properties on their release from a bioadhesive patch

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 63, Issue 3, 2006, Pages 295-309

  Gilmore, Brendan F ^a   McCarron, Paul A ^a   Morrow, Desmond I J ^a   Murphy, Diarmaid J ^a   Woolfson, A David ^a   Donnelly, Ryan F ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

5 Aminolevulinic acid; Bioadhesion; Drug delivery; Patches; Photodynamic therapy; Stratum corneum

Indexed keywords

ADHESIVE AGENT; AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; PORPHIN; PROTOPORPHYRIN;

ANIMAL TISSUE; ARTICLE; ARTIFICIAL MEMBRANE; CANCER CELL CULTURE; CELL DEATH; CONTROLLED STUDY; CREAM; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; IRRADIATION; MAXIMUM ALLOWABLE CONCENTRATION; MEDICAL LITERATURE; NONHUMAN; OINTMENT; PHOTOTOXICITY; SKIN DEFECT; STRATUM CORNEUM;

AMINOLEVULINIC ACID; CELL LINE, TUMOR; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG DELIVERY SYSTEMS; EPIDERMIS; HUMANS; MEMBRANES, ARTIFICIAL; OINTMENTS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; SKIN NEOPLASMS;

EID: 33646853695     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2006.03.002     Document Type: Article

References (59)

1. Dolmans D.E., Fukumura D., and Jain R.K. Photodynamic therapy for cancer. Nat. Rev. Cancer 3 (2003) 380-387
2. Soler A.M., Warloe T., Berner A., and Giercksky K.E. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolevulinate-based photodynamic therapy alone with prior curettage. Br. J. Dermatol. 145 (2001) 467-471
3. Morton C.A., Brown S.B., Collins S., Ibbotson S., Jenkinson H., Kurwa H., Langmack K., McKenna K., Moseley H., Pearse A.D., Stringer M., Taylor D.K., Wong G., and Rhodes L.E. Guidelines for topical photodynamic therapy: a report of a workshop of the British photodermatology group. Br. J. Dermatol. 146 (2002) 552-567
4. Fritsch C., Lang K., Neuse W., Ruzicka T., and Lehmann P. Photodynamic diagnosis and therapy in dermatology. Skin Pharmacol. Appl. Skin Physiol. 11 (1998) 358-373
5. Moan J., Van den Akker J.T.H.M., Juzenas P., Ma L.W., Angell-Peterson E., Gadmar O.B., and Iani V. On the basis for tumor selectivity in the 5-aminolevulinic acid-induced synthesis of protoporphyrin IX. J. Porph. Phthalocyan. 5 (2001) 170-176
6. Morton C.A., Whitehurst C., McColl J.H., Moore J.V., and MacKie R.M. Photodynamic therapy for large or multiple patches of Bowen's disease and basal cell carcinoma. Arch. Dermatol. 137 (2001) 319-324
7. Markham T., and Collins P. Topical 5-aminolevulinic acid photodynamic therapy for extensive scalp actinic keratoses. Br. J. Dermatol. 145 (2001) 502-504
8. Woolfson A.D., McCafferty D.F., McCallion C.R., McAdams E.T., and Anderson J.McC. Moisture-activated, electrically conducting bioadhesive hydrogels as interfaces for bioelectrodes: effect of film hydration on cutaneous adherence in wet environments. J. Appl. Polym. Sci. 58 (1995) 1291-1296
9. Fourtanier A., and Berrebi C. Miniature pig as an animal model to study photoaging. Photochem. Photobiol. 50 (1989) 771-784
10. Bretschko E., Szeimies R.M., Landthaler M., and Lee G. Topical 5-aminolevulinic acid for photodynamic therapy of basal cell carcinoma. Evaluation of stratum corneum permeability in vitro. J. Control. Release 42 (1996) 203-208
11. Lieb S., Szeimies R.M., and Lee G. Self-adhesive thin films for topical delivery of 5-aminolevulinic acid. Eur. J. Pharm. Biopharm. 53 (2002) 99-106
12. Bentley M.V.L.B., Vianna R.F., Wilson S., and Collett J.H. Characterization of the influence of some cyclodextrins on the stratum corneum from the hairless mouse. J. Pharm. Pharmacol. 49 (1997) 397-402
13. McCarron P.A., Woolfson A.D., Donnelly R.F., Andrews G.P., Zawislak A., and Price J.H. Influence of plasticiser type and storage conditions on the properties of poly(methyl vinyl ether-co-maleic anhydride) bioadhesive films. J. Appl. Polym. Sci. 91 (2004) 1576-1589
14. Kaliszewski M., Kwasny M., Kaminski J., Dabrowski Z., and Burdziakowska Z. The stability of 5-aminolevulinic acid and its ester derivatives. Acta Pol. Pharm. 61 (2004) 15-19
15. R.F. Donnelly, Bioadhesive Drug Delivery Systems for Photodynamic Therapy of Vulval Intraepithelial Neoplasia, PhD Thesis, Queens University Belfast, Belfast, UK, 2003.
16. Oishi H., Nomiyama H., Nomiyama K., and Tomokuni K. Fluorometric HPLC determination of 5-aminolevulinic acid (ALA) in the plasma and urine of lead workers: biological indicators of lead exposure. J. Anal. Toxicol. 20 (1996) 106-110
17. Gadmar O.B., Moan J., Scheie E., Ma L.W., and Peng Q. The stability of 5-aminolevulinic acid in solution. J. Photochem. Photobiol. B: Biol. 67 (2002) 187-193
18. J. Hanania, Z. Malik, The effect of EDTA and serum on endogenous porphyrins accumulation and photodynamic sensitization of human K562 leukemic cells, Cancer Lett. 65, 127-131.
19. Fuchs C., Riesenberg R., Siegert J., and Baumgartner R. pH-dependent formation of 5-aminolevulinic acid-induced protoporphyrin IX in fibrosarcoma cells. J. Photochem. Photobiol. B: Biol. 40 (1997) 49-54
20. Gomer C.J., Jester J.V., Razum N.J., Szirth B.C., and Murphree L. Photodynamic therapy of intraocular tumours. Examination of hematoporphyrin derivative distribution and long-term damage in rabbit ocular tissue. Cancer Res. 45 (1985) 3718-3725
21. Svanberg K., Andersson T., Killander D., Wang D., Stenram U., Andersson-Engels S., Berg R., Johansson J., and Svanberg S. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical 5-aminolevulinic acid sensitization and laser irradiation. Br. J. Dermatol. 130 (1994) 743-751
22. Dijkstra A.T., Majoie I.M.L., van Dongen J.W.F., van Weelden H., and van Vloten W.A. Photodynamic therapy with violet light and topical 5-aminolevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma. J. Eur. Acad. Dermatol. Venereol. 15 (2001) 550-554
23. Sziemies R.M., Sassy T., and Landthaler M. Penetration potency of topical applied 5-aminolevulinic acid for photodynamic therapy of basal cell carcinoma. Photochem. Photobiol. 59 (1994) 73-76
24. Itkin A., and Gilchrest B.A. Delta-aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome. Dermatol. Surg. 30 (2004) 1054-1061
25. ® Product Information Sheet, Medicell International, London, UK, 1998.
26. ® Product Information Sheet, Crawford Pharmaceuticals, Milton Keynes, UK, 1996.
27. Uehlinger P., Zellweger M., Wagnieres G., Juillerat-Jeanneret L., VanderBergh H., and Lange N. 5-Aminolevulinic acid and its derivatives: physical chemical properties and protoporphyrin IX formation in cultured cells. J. Photochem. Photobiol. B: Biol. 54 (2000) 72-80
28. Woolfson A.D., and McCafferty D.F. Percutaneous Local Anaesthesia (1993), Ellis Horwood, London, UK
29. Peng Q., Moan J., Warloe T., Iani V., Steen H.B., Bjorseth A., and Nesland J.M. Build-up of esterified aminolevulinic acid derivative-induced porphyrin fluorescence in normal mouse skin. J. Photochem. Photobiol. B: Biol. 34 (1996) 95-96
30. Berger Y., Greppi A., Siri O., Neier R., and Juillerat-Jeanneret L. Ethylene glycol and amino acid derivatives of 5-aminolevulinic acid as new photosensitising precursors of protoporphyrin IX in cells. J. Med. Chem. 43 (2000) 4738-4746
31. Berger Y., Ingrassia L., Neier R., and Juillerat-Jeanneret L. Evaluation of dipeptide-derivatives of 5-aminolevulinic acid as precursors for photosensitisers in photodynamic therapy. Bioorg. Med. Chem. 11 (2003) 1341-1351
32. Kloek J., and Beijersbergen Van Henegouwen M.J. Prodrugs of 5-aminolevulinic acid for photodynamic therapy. Photochem. Photobiol. 64 (1996) 994-1000
33. De Rosa F.S., Tedesco A.C., Lopez R.F.V., Pierre M.B.R., Lange N., Marchetti J.M., Rotta J.C.G., and Bentley M.V.L.B. In vitro permeation and retention of 5-aminolevulinic acid ester derivatives for photodynamic therapy. J. Control. Release 89 (2003) 261-269
34. Martin A., Swarbrick J., and Cammarata A. Physical Pharmacy (1983), Lea & Febiger, Philadelphia, USA
35. Winkler A., and Muller-Goymann C.C. Comparative permeation studies for 5-aminolevulinic acid and its n-butyl ester through stratum corneum and artificial skin constructs. Eur. J. Pharm. Biopharm. 53 (2002) 281-287
36. Tsai J.C., Chen H., Wong W., and Lo Y.L. In vitro/in vivo correlations between transdermal delivery of 5-aminolevulinic acid and cutaneous protoporphyrin IX accumulation and effect of formulation. Br. J. Dermatol. 146 (2002) 853-862
37. Lopez R.F., Lange N., Guy R.H., and Bentley M.V.L.B. Photodynamic therapy of skin cancer: controlled drug delivery of 5-ALA and its esters. Adv. Drug Deliv. Rev. 56 (2004) 77-94
38. ® Product Information Sheet. Galderma, Herts, UK, 2003.
39. Williams A.C. Transdermal and Topical Drug Delivery (2003), Pharmaceutical Press, London, UK
40. VandenAkker J.T.H.M., Holroyd J.A., Vernon D.I., Sterenborg H.J.C.M., and Brown S.B. Comparative in vitro percutaneous penetration of 5-aminolevulinic acid and two of its esters through excised hairless mouse skin. Lasers Surg. Med. 33 (2003) 173-181
41. Gerscher S., Connelly J.P., Griffiths J., Brown S.B., MacRobert A.J., Wong G., and Rhodes L.E. Comparison of the pharmacokinetics and phototoxicity of protoporphyrin IX metabolized from 5-aminolevulinic acid and two derivatives in human skin in vivo. Photochem. Photobiol. 72 (2000) 569-574
42. Gerscher S., Connelly J.P., Beijersbergen VanHenegouwen G.M.J., MacRobert A.J., Watt P., and Rhodes L.E. A quantitative assessment of protoporphyrin IX metabolism and phototoxicity in human skin following dose-controlled delivery of the prodrugs 5-aminolaevulinic acid and 5-aminolaevelunic acid-n-pentylester. Br. J. Dermatol. 144 (2001) 983-990
43. Peng Q., Soler A.M., Warloe T., Nesland J.M., and Giercksky K.E. Selective distribution of porphyrins in skin-thick basal cell carcinoma after topical application of methyl 5-aminolevulinate. J. Photochem. Photobiol. B: Biol. 62 (2001) 140-145
44. Moan J., Ma L.W., and Iani V. On the pharmacokinetics of topically applied 5-aminolevulinic acid and two of its esters. Int. J. Cancer 92 (2001) 139-143
45. Moan J., Ma L.W., Juzeniene A., Iani V., Juzenas P., Apricena F., and Peng Q. Pharmacology of protoporphyrin IX in nude mice after application of ALA and its esters. Int. J. Cancer 103 (2003) 132-135
46. Juzeniene A., Juzenas P., Iani V., and Moan J. Topical application of 5-aminolevulinic acid and its methylester, hexylester and octylester derivatives: considerations for dosimetry in mouse skin model. Photochem. Photobiol. 76 (2002) 329-334
47. Ahmadi S., McCarron P.A., Donnelly R.F., Woolfson A.D., and McKenna K. Evaluation of the penetration of 5-aminolevulinic acid through basal cell carcinoma: a pilot study. Exp. Dermatol. 13 (2004) 1-7
48. Moan J., Streckyte G., Bagdonas S., Bech O., and Berg K. Photobleaching of protoporphyrin IX in cells incubated with 5-aminolevulinic acid. Int. J. Cancer 70 (1997) 90-97
49. Musgrove E., Seaman M., and Hedley D. Relationship between cytoplasmic pH and proliferation during exponential growth and cellular quiescence. Exp. Cell Res. 172 (1987) 65-75
50. Schick E., Kaufmann R., Ruck A., Hainzl A., and Boehncke W.-H. On the effectiveness of photodynamic therapy. Acta Derm. Venerol. 75 (1995) 276-279
51. Bech O., Berg K., and Moan J. The pH dependancy of protoporphyrin IX formation in cells incubated with 5-aminolevulinic acid. Cancer Lett. 113 (1997) 25-29
52. Wyld L., Reed M.W.R., and Brown N.J. The influence of hypoxia and pH on aminolevulinic acid-induced photodynamic therapy in bladder cancer cells in vitro. Br. J. Cancer 77 (1998) 1621-1627
53. McCarron P.A., Donnelly R.F., Gilmore B.F., Woolfson A.D., McClelland R., Zawislak A., and Price J.H. Phototoxicity of 5-aminolevulinic acid in the HeLa cell line as an indicative measure of photodynamic effect after topical administration to gynaecological lesions of intraepithelial form. Pharm. Res. 21 (2004) 1871-1879
54. Xiang W., Weingandt H., Liebmann F., Klein S., Stepp H., Baumgartner R., and Hillemanns P. Photodynamic effects induced by aminolevulinic acid esters on human cervical carcinoma cells in culture. Photochem. Photobiol. 74 (2001) 617-623
55. McCarron P.A., Donnelly R.F., Woolfson A.D., and Zawislak A. Photodynamic therapy of vulval intraepithelial neoplasia using bioadhesive patch-based delivery of aminolevulinic acid. Drug Deliv. Sys. Sci. 3 (2003) 59-64
56. Zawislak A., McCarron P.A., McCluggage W.G., Price J.H., Donnelly R.F., McClelland H.R., Dobbs S.P., and Woolfson A.D. Successful photodynamic therapy of vulval Paget's disease using a novel patch-based delivery system containing 5-aminolevulinic acid. Br. J. Obstet. Gynaecol. 111 (2004) 1-3
57. McCarron P.A., Donnelly R.F., Woolfson A.D., Zawislak A., Price J.H., and Maxwell P. Photodynamic treatment of lichen sclerosus and squamous hyperplasia using sustained topical delivery of aminolevulinic acid from a Novel Bioadhesive. Br. J. Dermatol. 151 Suppl. 68 (2004) 105-106
58. R.F. Donnelly, L.W. Ma, P., Juzenas, V., Iani, P.A., McCarron, A.D. Woolfson, J. Moan, Topical bioadhesive patch systems enhance selectivity of protoporphyrin IX accumulation in tumours. Photochem. Photobiol. (2006), in press.
59. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human use. ICH-Topic Q2B: Validation of Analytical Procedures: Methodology. Geneva, 1996.